Insider: Gollob Jared Chief Medical Officer - Kymera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 117,134 | 0 | 117,134 |
| Value | $10,003,243.60 | $0.00 | $10,003,243.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 447 | Direct | COM | $86.62 | $38,721.24 | 117,134 |
| 03/04/2026 | DDS | 492 | Direct | COM | $84.00 | $41,326.28 | 121,537 |
| 03/04/2026 | DDS | 2,519 | Direct | COM | $85.04 | $214,206.69 | 119,018 |
| 03/04/2026 | DDS | 1,437 | Direct | COM | $85.78 | $123,266.87 | 117,581 |
| 03/02/2026 | DDS | 1,510 | Direct | COM | $87.75 | $132,503.86 | 126,132 |
| 03/02/2026 | DDS | 3,048 | Direct | COM | $89.66 | $273,275.76 | 122,029 |
| 03/02/2026 | DDS | 1,055 | Direct | COM | $88.50 | $93,367.92 | 125,077 |
| 12/08/2025 | DDS | 18,357 | Direct | COM | $88.02 | $1,615,810.68 | 127,183 |
| 12/08/2025 | DDS | 13,759 | Direct | COM | $87.37 | $1,202,138.96 | 145,540 |
| 12/08/2025 | DDS | 3,929 | Direct | COM | $89.43 | $351,356.33 | 123,254 |
| 12/08/2025 | DDS | 1,400 | Direct | COM | $92.19 | $129,066.00 | 109,992 |
| 12/08/2025 | DDS | 3,300 | Direct | COM | $91.46 | $301,830.87 | 111,392 |
| 12/08/2025 | DDS | 8,562 | Direct | COM | $90.12 | $771,629.70 | 114,692 |
| 10/15/2025 | DDS | 29,264 | Direct | COM | $60.37 | $1,766,667.68 | 140,304 |
| 10/15/2025 | DDS | 8,963 | Direct | COM | $61.49 | $551,160.86 | 131,341 |
| 10/15/2025 | DDS | 14,896 | Direct | COM | $62.72 | $934,326.28 | 116,445 |
| 10/15/2025 | DDS | 6,453 | Direct | COM | $63.09 | $407,099.12 | 109,992 |
| 10/13/2025 | DDS | 3,114 | Direct | COM | $60.00 | $186,840.00 | 118,359 |
| 03/03/2025 | DDS | 4,695 | Direct | COM | $30.33 | $142,385.73 | 121,045 |
| 03/03/2025 | DDS | 1,045 | Direct | COM | $31.00 | $32,399.81 | 120,000 |
| 07/16/2024 | DDS | 13,281 | Direct | COM | $45.59 | $605,521.96 | 105,604 |
| 07/16/2024 | DDS | 9,864 | Direct | COM | $46.10 | $454,695.88 | 95,470 |
| 07/15/2024 | DDS | 16,455 | Direct | COM | $45.15 | $742,925.15 | 95,740 |
| 03/04/2024 | DDS | 2,022 | Direct | COM | $41.41 | $83,738.10 | 97,062 |
| 03/04/2024 | DDS | 1,106 | Direct | COM | $42.39 | $46,885.99 | 95,956 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research